Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© 2019 John Wiley & Sons, Ltd. Glucose-substituted ruthenium complexes [(η6-benzyl-glucose)RuCp*]+Cl−, where Cp* = η5-C5Me5; benzyl-glucose = peracetylated benzyl β-d-glucopyranoside (1), benzyl β-d-glucopyranoside (2), have been prepared and used as efficient antimigration and anti-invasive agents against metastatic breast cancer cells (MDA-MB-231) and cisplatin-resistant ovarian cancer cells (SK-OV-3). In addition, these complexes were found to be essentially non-toxic against non-cancerous human kidney cells (HEK293).

Original publication

DOI

10.1002/aoc.5318

Type

Journal article

Journal

Applied Organometallic Chemistry

Publication Date

01/01/2020

Volume

34